bioMD (BOD)

Shares / Stock Code


Stock Exchange / Sharemarket


bioMD (BOD) is an Australian biotechnology company specialising in bringing safer and more innovative medical devices to the healthcare market. The company has invested in a suite of injection therapy products aimed at preventing needlestick injuries in the following healthcare sectors: subcutaneous needle injections; prefilled safety syringe market for the pharmaceutical industry; safety syringes for the illicit drug user market and prefilled dental injection market.

BOD has a collaborative research agreement with CSIRO to develop a new material for use in the manufacture of medical devices. It is intended the new material will have application initially in the vascular access market but will have wider application in medical devices used for various forms of infusion therapy. BOD has the exclusive right to negotiate a licence with CSIRO for use of the resulting intellectual property for a period of 15 years on a worldwide basis.

bioMD History

BOD was listed on the ASX in March 2004 after a successful capital raising. It was from this IPO that funds were received, enabling the company to purchase a suite of developmental safety injection therapy products. BOD has achieved Quality Assurance Accreditation to Australian Standard ISO 9001:2000 and the system complies with AS ISO 13485:2003. Regular reviews are conducted by certification specialists to ensure compliance.

bioMD (BOD) Products and Services

  • Development and commercialisation of safety-engineered medical devices

bioMD (BOD) Locations and Subsidiaries

bioMD Head Office
225 St Georges Tce, Level 11,
WA 6000

Phone: (08) 9262 6777
Fax: (08) 9322 3433

Company Website

bioMD (BOD) Share Price

Submitted by ASX Listed Company on 1 March, 2010 - 01:46